Accreditation

0.5 AMA PRA Category 1 Credit(s)™.
Read the full Accreditation Statement

Target Audience

Directed to gastroenterologists, infectious disease physicians, infectious disease and gastroenterology nurse practitioners, infection control nurses, physician assistants, and managed care organizations.

Description

The Hepatitis C Management Series includes interactive cases, corresponding to the Hepatitis C Management Monograph.

Throughout the interactive case, you may proceed to the next question once you answer each question correctly. In addition to allowing you to proceed, the correct answer also reveals the rationale for the answer.

Upon completing the CME activity, the evaluation and registration forms, you will have the opportunity to print a CME certificate. 

Objectives

At the conclusion of this activity, the participant will be able to:

1. Identify predictors of favorable response to therapy.
2. Discuss the common side effects and toxicities associated with interferon and ribavirin therapy and their management.
3. Review suggested strategies to screen for hepatocellular carcinoma in patients with hepatitis C and cirrhosis.

Activity Director

William D. Carey, MD
Department of Gastroenterology & Hepatology
The Cleveland Clinic
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio

Author

Nizar N. Zein, MD

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they do not have a relationship which, in the context of their presentations, could be perceived as a potential conflict of interest.

Nizar N. Zein, MD
William D. Carey, MD